L-Lysinol
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Others |
| Catalog number | BBF-04750 |
| CAS | 110690-36-3 |
| Molecular Weight | 132.21 |
| Molecular Formula | C6H16N2O |
Online Inquiry
Specification
| Synonyms | H-Lys-ol; (S)-2,6-Diaminohexan-1-ol; (2S)-2,6-Diaminohexan-1-ol |
| Storage | Store at 2-8 °C |
| IUPAC Name | (2S)-2,6-diaminohexan-1-ol |
| Canonical SMILES | C(CCN)CC(CO)N |
| InChI | InChI=1S/C6H16N2O/c7-4-2-1-3-6(8)5-9/h6,9H,1-5,7-8H2/t6-/m0/s1 |
| InChI Key | LTGPFZWZZNUIIK-LURJTMIESA-N |
Reference Reading
1. Synthesis of protected 3-aminopiperidine and 3-aminoazepane derivatives using enzyme cascades
Grayson J Ford, Nico Kress, Ashley P Mattey, Lorna J Hepworth, Christopher R Baldwin, James R Marshall, Lisa S Seibt, Min Huang, William R Birmingham, Nicholas J Turner, Sabine L Flitsch Chem Commun (Camb). 2020 Jul 21;56(57):7949-7952. doi: 10.1039/d0cc02976a. Epub 2020 Jun 12.
Multi-enzyme cascades utilising variants of galactose oxidase and imine reductase led to the successful conversion of N-Cbz-protected l-ornithinol and l-lysinol to l-3-N-Cbz-aminopiperidine and l-3-N-Cbz-aminoazepane respectively, in up to 54% isolated yield. Streamlining the reactions into one-pot prevented potential racemisation of key labile intermediates and led to products with high enantiopurity.
Recommended Products
| BBF-05817 | Astaxanthin | Inquiry |
| BBF-02800 | DB-2073 | Inquiry |
| BBF-00693 | Ansamitocin P-3 | Inquiry |
| BBF-05843 | Bacitracin | Inquiry |
| BBF-03915 | Clavulanate Potassium (1:1 mixture with silicon dioxide) | Inquiry |
| BBF-03794 | Geneticin sulfate | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
